Search clinical trials for: VI-RADS

Total 899 results

Istituto Nazionale di Ricovero e Cura per Anziani

Completed

Diagnostic Performance of the Vesical Imaging-Reporting and Data System (VI-RADS) in Detecting Muscle-invasive Bladder Tumour (MIBC) in Clinical Practice: Comparison With Transurethral Resection of Bladder Cancer (TURB) and Evaluation of Diagnostic Accuracy According to Tumour Location (VI-RADS)

Bladder Cancer

Italy
Novartis

Completed

Safety and Immunogenicity of Three Formulations of Vi-CRM197 Vaccine Against S. Typhi in Adults (18-40 Years Old)

Typhoid Fever

Belgium
GlaxoSmithKline

Completed

A 24-week Study to Evaluate the Efficacy and Safety of GSK573719/GW642444 125/25 mcg and 62.5/25mcg Inhalation Powder Compared With Placebo in Subjects With COPD

Pulmonary Disease, Chronic Obstructive

Taiwan, Thailand, China, Philippines, Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Study of a Single Dose of SP093 Typhoid Vi Polysaccharide Vaccine in Japanese Subjects

Bacterial Infections | Typhoid Fever | Salmonella Infections

Japan
fan li

Completed

Virtual Ileostomy Versus Diverting Ileostomy

Rectal Cancer

China
Kathleen Neuzil
Groupe de Recherche Action en Sante

Completed

Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso

Typhoid

Burkina Faso
University of Oxford

Completed

Vaccines Against Salmonella Typhi (VAST)

Typhoid Fever | Enteric Fever

United Kingdom
International Centre for Diarrhoeal Disease Research...

Completed

Non-inferiority Trial of Locally Manufactured Typhoid Conjugate Vaccine 'Typhocon' in Bangladesh

Typhoid

Bangladesh
VA Office of Research and Development
Baylor College of Medicine

Completed

A Culturally Sensitive Values-Guided Aid for End of Life Decision-Making (Aim3)

Chronic Obstructive Pulmonary Disease | Lung Cancer | Chronic Kidney Disease | Cirrhosis | Congestive Heart Failure | Colon Carcinoma

United States
International Vaccine Institute
SK Chemicals Co., Ltd.

Completed

Safety and Immunogenicity of a Vi-DT Typhoid Conjugate Vaccine

Typhoid
GlaxoSmithKline

Completed

Pharmacokinetics Of Umeclidinium and Vilanterol in Healthy Chinese, a Randomized, Open Label, 3 Crossover Study.

Pulmonary Disease, Chronic Obstructive

China
Medical University of Graz
CBmed Ges.m.b.H.

Active, not recruiting

Post COVID-19 Syndrome and the Gut-lung Axis

Covid19

Austria
Loewenstein Hospital

Unknown

tDCS and VI to Treat Neuropathic Pain and Function in SCI

SCI - Spinal Cord Injury
GlaxoSmithKline

Recruiting

A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma

Asthma

United States, Australia, Argentina, New Zealand, South Korea, Chile
GlaxoSmithKline

Completed

Efficacy and Safety of Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC/VI) in Chinese Participants With Inadequately Controlled Asthma

Asthma

China
DongGuk University

Completed

Comparison of Endotracheal Intracuff Pressure Between Two Cuff Sealing Methods

Endotracheal Tube

Korea, Republic of
University of Maryland, Baltimore
Bill and Melinda Gates Foundation; Groupe de Recherche Action en Sante

Completed

Typhoid Conjugate Vaccine Trial Among Children Younger Than 2 Years in Ouagadougou, Burkina Faso

Typhoid

Burkina Faso
VIVUS LLC

Not yet recruiting

A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations (TRANSCEND)

Pulmonary Arterial Hypertension | Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH) | Pulmonary Arterial Hypertension (PAH) | Pulmonary Arterial Hypertension WHO Group I | Pulmonary Arterial Hypertension PAH
GlaxoSmithKline
Optum-data vendor

Completed

Chronic Obstructive Pulmonary Disease (COPD) Dual Therapy Burden of Illness

Pulmonary Disease, Chronic Obstructive

United States
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine in Indonesian Adults, Adolescents, Children and Infants

Safety Issues | Immunogenicity

Indonesia
GlaxoSmithKline

Completed

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

United States, Romania, Russian Federation, Ukraine, Germany, Hungary, Bulgaria
Novartis

Completed

Extension Study of H01_04TP to Evaluate the Booster Response Induced by Vi-CRM197 in Adults

Typhoid Fever

Belgium
GlaxoSmithKline
Parexel

Completed

A Study to Assess the Systemic Exposure, Systemic Pharmacodynamics and Safety and Tolerability of FluticasoneFuroate, Umeclidinium and Vilanterol in Healthy Subjects

Pulmonary Disease, Chronic Obstructive

United States
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

Inflammation and Threat Sensitivity in PTSD (K01)

Posttraumatic Stress Disorder

United States
University of California, San Francisco
National Institute of Mental Health (NIMH)

Completed

Cognitive, Emotional, and Neural Responses to Acute Inflammation

Healthy

United States
Novartis

Completed

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Typhoid Fever

Belgium
Hospital Sirio-Libanes

Completed

Diaphragm Activity During Incentive Spirometry and Diaphragmatic Breathing

Breathing Exercises | Incentive Spirometry | Diaphragmatic Breathing | Diaphragm Mobility

Brazil
International Vaccine Institute
University of Cambridge; Institute of Tropical Medicine, Belgium; Institut National...

Recruiting

Effectiveness of a Typhoid Conjugate Vaccine in DRC (TyVECO)

Typhoid Fever

Congo, The Democratic Republic of the
International Vaccine Institute
Bill and Melinda Gates Foundation; SK Bioscience Co., Ltd.

Completed

Immune Equivalence Between Multi-dose and Single Dose Formulation of Vi-DT and Their Overall Safety (Phase III)

Typhoid

Philippines
Marquette University

Completed

READI (Readiness Evaluation And Discharge Interventions) Study (READI)

Discharge Transition of Patients Discharged to Home

United States
University of Maryland, Baltimore
University College, London; Bill and Melinda Gates Foundation; Malawi-Liverpool-Wellcome... and other collaborators

Active, not recruiting

Clinical Efficacy of Typhoid Conjugate Vaccine (Vi-TCV) Among Children Age 9 Months Through 12 Years in Blantyre, Malawi

Typhoid

Malawi
International Vaccine Institute
Wellcome Trust; Centers for Disease Control and Prevention; University of Western... and other collaborators

Completed

Typhoid Vi Vaccine Effectiveness in Hechi, Guangxi, China

Typhoid | Paratyphoid Fever

China
PT Bio Farma

Completed

Immunogenicity and Safety of Vi-DT (Diphtheria Toxoid) Typhoid Conjugate Vaccine (Phase III)

Safety Issues | Immunogenicity

Indonesia
International Vaccine Institute
University of Maryland, Baltimore; International Centre for Diarrhoeal Disease... and other collaborators

Recruiting

Evaluation of Typhoid Conjugate Vaccine Effectiveness in Ghana (TyVEGHA)

Typhoid Fever

Ghana
National Institute of Allergy and Infectious Diseases...

Completed

CVD 909 Vi Prime Boost Study

Typhoid Fever

United States
PT Bio Farma
Indonesia University

Completed

Persistence and Long-Term Protection of Vi Antibodies Induced by Vi-DT Conjugate Vaccines in Indonesian

Vaccine

Indonesia
VIVUS LLC
Medpace, Inc.

Completed

VI-1121 for the Treatment Alzheimer's Disease (AD-201)

Alzheimer's Disease

United States
University of Oxford
Mahidol University; Ministry of Health, Thailand

Recruiting

Iron Fortified Food to Improve Japanese Encephalitis and Typhoid Fever Vaccine Immunogenicity

Iron Deficiency Anemia

Thailand
PT Bio Farma

Completed

Safety and Immunogenicity of Vi-DT Typhoid Conjugate Vaccine (Bio Farma) in Adults and Children (Phase I)

Safety Issues

Indonesia
Hyun Park

Recruiting

Efficacy and Safety Evaluation of Vi-sealer

Benign Gynecologic Neoplasm

Korea, Republic of
University of Virginia
CSL Behring; Jeffrey Modell Foundation

Completed

Undetectable IgE as a Sentinel Biomarker for Humoral Immunodeficiency

Immune Deficiency

United States
International Vaccine Institute
GlaxoSmithKline; Wellcome Trust; National Institute of Hygiene and Epidemiology... and other collaborators

Completed

Introduction of the Vi Polysaccharide Typhoid Vaccine in Hue City, Central Vietnam

Typhoid | Paratyphoid Fever

Vietnam
International Centre for Diarrhoeal Disease Research...
Zydus Lifesciences Limited

Not yet recruiting

ZyVac-TCV Bangladesh Study

Typhoid Fever | Typhoid | Typhoid Vaccination

Bangladesh
Western University, Canada

Not yet recruiting

129-Xe MRI Study of Single Triple Therapy Inhaler Effects in COPD Patients With Moderate-severe Dyspnea and/or Poor Health Status With High or Low Risk of Exacerbation (MUST)

Chronic Obstructive Pulmonary Disease (COPD)
International Vaccine Institute
Bill and Melinda Gates Foundation; SK Bioscience Co., Ltd.

Completed

Safety, Reactogenicity and Immunogenicity of Vi-DT;Typhoid Conjugate Vaccine

Typhoid

Philippines
Jessa Hospital

Active, not recruiting

Photobiomodulation Therapy in the Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy (NeuroLight)

Chemotherapy-induced Peripheral Neuropathy

Belgium
EuBiologics Co.,Ltd

Completed

Safety and Tolerability of Typhoid Conjugate Vaccine (EuTCV) in Healthy Adults

Typhoid Fever

Philippines
Eunice Kennedy Shriver National Institute of Child...

Completed

Safety, Immunogenicity and Compatibility With DTP of a Typhoid Fever Vaccine in Infants

Typhoid Fever

Vietnam
Jessa Hospital

Recruiting

Photobiomodulation Therapy in the Management of Chemotherapy-Induced Peripheral Neuropathy (NeuroLight 2)

Chemotherapy-induced Peripheral Neuropathy

Belgium
Beni-Suef University

Completed

(GI-RADS) in Preoperative Evaluation of Adnexal Masses

Ovarian Cancer

Egypt

Search clinical trials for: VI-RADS

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cote d'Ivoire

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations